Lennard W. Lee

Standing Way
Milton Keynes, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

The Time for Cancer Vaccines Is Now: Advancing Toward Lasting Cancer Immunity.

The Time for Cancer Vaccines Is Now: Advancing Toward Lasting Cancer Immunity.

Journal: JAMA oncology

Published: February 12, 2026

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.

Journal: Frontiers in artificial intelligence

Published: January 26, 2026

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.

Journal: The Lancet. Oncology

Published: December 25, 2025

The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles.

The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles.

Journal: EClinicalMedicine

Published: February 13, 2025

Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial.

Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial.

Journal: Frontiers in oncology

Published: February 12, 2025

Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints.

Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints.

Journal: Immunotherapy advances

Published: December 31, 2024

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens.

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens.

Journal: Vaccines

Published: November 13, 2024

Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now.

Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now.

Journal: Infectious diseases (London, England)

Published: November 01, 2024

The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma.

The effect of time from surgery to commencing adjuvant radiotherapy for patients with head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: September 26, 2024

Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network.

Developing a digital phenotype to subdivide adult immunosuppressed COVID-19 outcomes within the English Primary Care Sentinel Network.

Journal: Frontiers in immunology

Published: September 09, 2024

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

Journal: The oncologist

Published: June 18, 2024

Independent SAGE as an example of effective public dialogue on scientific research.

Independent SAGE as an example of effective public dialogue on scientific research.

Journal: Nature protocols

Published: June 05, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026